Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein

Sergio Abrignani, Daniela Montagna, Michel Jeannet, Joelle Wintsch, Nancy Haigwood, Jeffrey R. Shuster, Kathelyn S. Steimer, André Cruchaud, Theophil Staehelin

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

A nonglycosylated denatured form of human immunodeficiency virus (HIV) 1 glycoprotein gp120 (Env 2-3), which does not bind to CD4, was used with muramyl tripeptide as adjuvant to immunize HIV-seronegative healthy volunteers. In all the volunteers, three 50-μg injections of Env 2-3 induced priming of CD4+ T cells specific for conserved regions of the native glycosylated gp120. Moreover, we found that several major histocompatibility complex class II (DR) alleles can function as restriction molecules for presentation of conserved epitopes of gp120 to T cells, implying that a T-cell response to these epitopes can be obtained in a large fraction of the population. The possibility to prime CD4+ T cells specific for conserved epitopes of a HIV protein is particularly important in view of the lack of such cells in HIV-infected individuals and of a possible role that CD4+ T cells may play in the development of protective immunity against AIDS.

Original languageEnglish (US)
Pages (from-to)6136-6140
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume87
Issue number16
StatePublished - Aug 1990
Externally publishedYes

Fingerprint

Recombinant Proteins
Glycoproteins
HIV
T-Lymphocytes
Epitopes
env Gene Products
Human Immunodeficiency Virus Proteins
Major Histocompatibility Complex
HIV-1
Volunteers
Immunity
Healthy Volunteers
Acquired Immunodeficiency Syndrome
Alleles
Injections
Population

Keywords

  • AIDS
  • Vaccination

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein. / Abrignani, Sergio; Montagna, Daniela; Jeannet, Michel; Wintsch, Joelle; Haigwood, Nancy; Shuster, Jeffrey R.; Steimer, Kathelyn S.; Cruchaud, André; Staehelin, Theophil.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 16, 08.1990, p. 6136-6140.

Research output: Contribution to journalArticle

Abrignani, Sergio ; Montagna, Daniela ; Jeannet, Michel ; Wintsch, Joelle ; Haigwood, Nancy ; Shuster, Jeffrey R. ; Steimer, Kathelyn S. ; Cruchaud, André ; Staehelin, Theophil. / Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein. In: Proceedings of the National Academy of Sciences of the United States of America. 1990 ; Vol. 87, No. 16. pp. 6136-6140.
@article{0d35a044967b4824a3c173c409f67103,
title = "Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein",
abstract = "A nonglycosylated denatured form of human immunodeficiency virus (HIV) 1 glycoprotein gp120 (Env 2-3), which does not bind to CD4, was used with muramyl tripeptide as adjuvant to immunize HIV-seronegative healthy volunteers. In all the volunteers, three 50-μg injections of Env 2-3 induced priming of CD4+ T cells specific for conserved regions of the native glycosylated gp120. Moreover, we found that several major histocompatibility complex class II (DR) alleles can function as restriction molecules for presentation of conserved epitopes of gp120 to T cells, implying that a T-cell response to these epitopes can be obtained in a large fraction of the population. The possibility to prime CD4+ T cells specific for conserved epitopes of a HIV protein is particularly important in view of the lack of such cells in HIV-infected individuals and of a possible role that CD4+ T cells may play in the development of protective immunity against AIDS.",
keywords = "AIDS, Vaccination",
author = "Sergio Abrignani and Daniela Montagna and Michel Jeannet and Joelle Wintsch and Nancy Haigwood and Shuster, {Jeffrey R.} and Steimer, {Kathelyn S.} and Andr{\'e} Cruchaud and Theophil Staehelin",
year = "1990",
month = "8",
language = "English (US)",
volume = "87",
pages = "6136--6140",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "16",

}

TY - JOUR

T1 - Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein

AU - Abrignani, Sergio

AU - Montagna, Daniela

AU - Jeannet, Michel

AU - Wintsch, Joelle

AU - Haigwood, Nancy

AU - Shuster, Jeffrey R.

AU - Steimer, Kathelyn S.

AU - Cruchaud, André

AU - Staehelin, Theophil

PY - 1990/8

Y1 - 1990/8

N2 - A nonglycosylated denatured form of human immunodeficiency virus (HIV) 1 glycoprotein gp120 (Env 2-3), which does not bind to CD4, was used with muramyl tripeptide as adjuvant to immunize HIV-seronegative healthy volunteers. In all the volunteers, three 50-μg injections of Env 2-3 induced priming of CD4+ T cells specific for conserved regions of the native glycosylated gp120. Moreover, we found that several major histocompatibility complex class II (DR) alleles can function as restriction molecules for presentation of conserved epitopes of gp120 to T cells, implying that a T-cell response to these epitopes can be obtained in a large fraction of the population. The possibility to prime CD4+ T cells specific for conserved epitopes of a HIV protein is particularly important in view of the lack of such cells in HIV-infected individuals and of a possible role that CD4+ T cells may play in the development of protective immunity against AIDS.

AB - A nonglycosylated denatured form of human immunodeficiency virus (HIV) 1 glycoprotein gp120 (Env 2-3), which does not bind to CD4, was used with muramyl tripeptide as adjuvant to immunize HIV-seronegative healthy volunteers. In all the volunteers, three 50-μg injections of Env 2-3 induced priming of CD4+ T cells specific for conserved regions of the native glycosylated gp120. Moreover, we found that several major histocompatibility complex class II (DR) alleles can function as restriction molecules for presentation of conserved epitopes of gp120 to T cells, implying that a T-cell response to these epitopes can be obtained in a large fraction of the population. The possibility to prime CD4+ T cells specific for conserved epitopes of a HIV protein is particularly important in view of the lack of such cells in HIV-infected individuals and of a possible role that CD4+ T cells may play in the development of protective immunity against AIDS.

KW - AIDS

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=0025164009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025164009&partnerID=8YFLogxK

M3 - Article

C2 - 1696717

AN - SCOPUS:0025164009

VL - 87

SP - 6136

EP - 6140

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 16

ER -